StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research note released on Wednesday morning. The firm issued a hold rating on the stock.
Brooklyn ImmunoTherapeutics Stock Performance
Shares of NYSE BTX opened at $7.37 on Wednesday. Brooklyn ImmunoTherapeutics has a 1 year low of $6.66 and a 1 year high of $8.31. The firm’s 50 day moving average price is $1.07 and its 200 day moving average price is $1.08. The firm has a market cap of $433.55 million, a P/E ratio of -3.25 and a beta of 4.61.
About Brooklyn ImmunoTherapeutics
Read More
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- Retail Stocks Investing, Explained
- Buffett’s on the Sidelines – Should You Follow?
- There Are Different Types of Stock To Invest In
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- Breakout Stocks: What They Are and How to Identify Them
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
